4basebio Plc - Appointment of Joint Corporate Broker
("4basebio" or the "Company")
Appointment of Joint Corporate Broker
Enquiries
4basebio PLC +44 (0)1223 967 943 Dr.Heikki Lanckriet Joint Corporate BrokerRBC Capital Markets +44 (0)20 7653 4000Rupert Walford /Kathryn Deegan Joint Corporate BrokerCavendish Capital Markets Limited +44 (0)20 7220 0500Geoff Nash /Nigel Birks Nominated AdviserCairn Financial Advisers LLP +44 (0)20 7213 0880Jo Turner /Sandy Jamieson /Ed Downes
Notes to Editors
About 4basebio
4basebio (AIM: 4BB) is an innovation driven life biotechnology company focused on accelerating the development of advanced therapy medicinal products (ATMPs) through its high-performance synthetic DNA products and non-viral, cell targeting nucleic acid delivery platform. The Company’s objective is to become a market leader in the manufacture and supply of high-quality synthetic DNA products for research, therapeutic and pharmacological use as well as development of target specific non-viral vectors for the efficient delivery of payloads in patients.